30 parallel-processing-bioinformatics-"Multiple" positions at University College London
Sort by
Refine Your Search
-
of neuroscience. The Department hosts multiple large-scale collaborative grants including the Wellcome-funded Discovery Research Platform for Naturalistic Neuroimaging, and the Max Planck UCL Centre
-
adjustments or a more accessible format to apply for this job online, or have any queries regarding the application process, please contact the Institute of Neurology HR Team (ion.hradmin@ucl.ac.uk ). Informal
-
externally. You bring creativity, initiative and enthusiasm to everything you do, and your time management is exceptional. Whether juggling multiple projects or working to tight deadlines, you stay organised
-
, initiative and enthusiasm to everything you do, and your time management is exceptional. Whether juggling multiple projects or working to tight deadlines, you stay organised, efficient and focused on delivery
-
. The EnzAct Prosperity Partnership, funded by BBSRC & EPSRC, aims to accelerate Unilever’s path to sustainability with enzymatic processes to create the next generation of surfactants, fragrances, and
-
processes by providing information- and technology-related services to over 50,000 staff and students of UCL and associated institutions. Our ambition is to be the leading IT services group in the HE sector
-
MClinDent programme in Periodontology, involvement in clinical teaching and curriculum development, and participation in examination processes. The role also includes contributions to research activities
-
, Division of Infection and Immunity, Division of Surgery and Interventional Sciences and the UCL Medical School – the Faculty of Medical Sciences (FMS) offers a unique mix of pioneering research, best in
-
the interview process. Term dates would be... 🗓️ Term Dates 2025–2026 Autumn Term Term dates: Monday 1 September – Friday 19 December 2025 Half-term break: Monday 27 October – Friday 31 October 2025 Christmas
-
to Treat Mitochondrial Diseases (LAC-TreatMito-UK) was established in September 2024 to deliver a national platform to translate novel treatment strategies and biomarkers into clinical trials. This platform